Skip to content

News Category: Health & Medical

Albumedix and Heartseed announce Recombumin(R) as a critical excipient in the manufacture of Heartseed’s HS-001 investigational cell therapy as its first in-human trial commences

By asianet

Albumedix Ltd (‘Albumedix’), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc (‘Heartseed’), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin(R) is a critical component of Heartseed’s HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing. – Recombumin, an animal and human origin … Continued

NCODA International Executive Council to Advance Medically Integrated Oncology Worldwide

By asianet

NCODA ( https://c212.net/c/link/?t=0&l=en&o=3800098-1&h=2079229491&u=https%3A%2F%2Fwww.ncoda.org%2F&a=NCODA ) a non-profit organization whose Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes is proud to announce the formation of its International Executive Council (IEC). The IEC will provide insight and leadership to NCODA regarding meeting the ever-changing needs of oncology patients and healthcare professionals around the … Continued

NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally

By asianet

– Compiles “NX-Pharma Global Quality Manual” and Appoints Head of NX-Pharma Global Quality – NIPPON EXPRESS HOLDINGS, INC., based in Tokyo, has compiled the NX-Pharma Global Quality Manual, applicable as of Sunday, January 1, 2023, to unify and standardize pharmaceutical logistics quality standards on a global basis. Logo: https://kyodonewsprwire.jp/img/202303013462-O1-7reh962D Image: NX-Pharma Global Quality Manual https://kyodonewsprwire.jp/prwfile/release/M103866/202303013462/_prw_PI2fl_yksd5VnD.jpg … Continued

Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX(R) Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)

By asianet

– CELLEX ECP is now available for reimbursement in Japan for patients who are steroid-resistant or -intolerant and suffering from cGvHD – Mallinckrodt plc ( https://c212.net/c/link/?t=0&l=en&o=3801942-1&h=3085666488&u=http%3A%2F%2Fwww.mallinckrodt.com%2F&a=Mallinckrodt+plc ), (NYSE American: MNK) (“Mallinckrodt” or the “Company”), a global specialty pharmaceutical company, today announced that Japan’s National Health Insurance (NHI) system has approved reimbursement for the CELLEX(R) extracorporeal … Continued

Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise

By asianet

Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO Leadership Award (https://www.cmoleadershipawards.com/) across all six categories – capability, compatibility, expertise, quality, reliability and service across all three groups of respondents (Big Pharma, Small Pharma, and Overall (combined Big and Small Pharma)). Hovione was given additional recognition as a CDMO Leadership Award … Continued

Japan’s Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients

By asianet

Saitama Medical University International Medical Center, one of Japan’s leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global real-world data to better understand rare diseases, treatments, and outcomes, as well as provide additional clinical trial opportunities to its patients. Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg “Novel therapies may … Continued

Japan’s Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Trials

By asianet

Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX to increase its exposure and participation in multi-national industry-sponsored clinical trials. Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg “The use of Japanese pharmaceuticals has dropped from 20% to less than … Continued

Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase

By asianet

Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce the development of a new enzyme for double strand oligonucleotide formation with high productivity. Logo – https://mma.prnewswire.com/media/751177/Aji_BioPharma_Logo.jpg In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA … Continued

Bugworks Research Inc welcomes Dr. Renu Swarup to its Global Advisory Board

By asianet

Former secretary of the Department of Biotechnology, Government of India and reputed Biotechnologist joins the Advisory Board to provide strategic guidance to the project portfolio of Bugworks Research Bugworks Research, a clinical-stage biopharmaceutical company, has engaged Dr. Renu Swarup as a honorary member of the Global Advisory Board. Dr. Swarup is the former Secretary, Department … Continued

Nippon Express Singapore Receives IATA CEIV Pharma Certification for Changi International Airport Facility

By asianet

Nippon Express (Singapore) Pte. Ltd. (hereinafter “NX Singapore”), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma (*) certification for its facility in the Free Trade Zone (FTZ) at Singapore Changi International Airport, effective Wednesday, January 17, 2023. Logo: https://kyodonewsprwire.jp/img/202302152976-O1-mlDJ2Ge9 Photo: https://kyodonewsprwire.jp/prwfile/release/M103866/202302152976/_prw_PI2fl_2k7X0YXf.jpg The pharmaceutical/medical sector, one of Singapore’s priority industries, has … Continued